Works by Koehler, Amber B.

Results: 17
    1

    Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation‐Wide Study.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 9, p. 1678, doi. 10.1002/ajh.27747
    By:
    • Tsang, Mazie;
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Brieghel, Christian;
    • Ding, Wei;
    • Leis, Jose F.;
    • Hilal, Talal;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Van Dyke, Daniel L.;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Hjalgrim, Henrik;
    • Niemann, Carsten U.;
    • Parikh, Sameer A.;
    • Rotbain, Emelie C.
    Publication type:
    Article
    2

    Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. E318, doi. 10.1002/ajh.27060
    By:
    • Kosydar, Samuel R.;
    • Parikh, Sameer A.;
    • Lester, Scott C.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Burlile, Jessica F.;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Call, Timothy G.;
    • Breen, William G.;
    • Hampel, Paul J.
    Publication type:
    Article
    3

    Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 2, p. 239, doi. 10.1111/bjh.18357
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Shi, Min;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    4
    5

    DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 739, doi. 10.1002/ajh.26888
    By:
    • Huntington, Scott F.;
    • Schuster, Stephen J.;
    • Ding, Wei;
    • Koehler, Amber B.;
    • Brander, Danielle M.;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Tun, Han W.;
    • Moustafa, Muhamad Alhaj;
    • Iqbal, Madiha;
    • He, Wei;
    • Kearney, Albert S.;
    • McKinlay, Timothy P.;
    • Gui, Min;
    • Mato, Anthony R.
    Publication type:
    Article
    6

    Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 1, p. 90, doi. 10.1002/ajh.26388
    By:
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Johnson, Michael J.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Hayman, Suzanne R.;
    • Wang, Yucai;
    • Hampel, Paul J.;
    • Holets, Matthew A.;
    • Darby, Heather C.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Miao, Congrong;
    • Canniff, Jennifer;
    • Whitaker, Jennifer A.;
    • Levin, Myron J.;
    • Schmid, D. Scott
    Publication type:
    Article
    7

    The prognostic significance of del6q23 in chronic lymphocytic leukemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 6, p. E203, doi. 10.1002/ajh.26168
    By:
    • Audil, Hadiyah Y.;
    • Hampel, Paul J.;
    • Van Dyke, Daniel L.;
    • Achenbach, Sara J.;
    • Rabe, Kari G.;
    • Smoley, Stephanie A.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Parikh, Sameer A.
    Publication type:
    Article
    8

    Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. E57, doi. 10.1002/ajh.25690
    By:
    • Hampel, Paul J.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Muchtar, Eli;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Leis, Jose F.;
    • Witzig, Thomas E.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Rabe, Kari G.;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    9

    The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 10, p. 3390, doi. 10.1002/cam4.2998
    By:
    • Parikh, Sameer A.;
    • Achenbach, Sara J.;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Chanan‐Khan, Asher A.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Muchtar, Eli;
    • Fonder, Amie L.;
    • McCullough, Kristen B.;
    • Nedved, Adrienne N.;
    • Smith, Matthew D.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Finnes, Heidi D.;
    • Shanafelt, Tait D.
    Publication type:
    Article
    10

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    11
    12

    Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00477-5
    By:
    • Wang, Yucai;
    • Sinha, Sutapa;
    • Wellik, Linda E.;
    • Secreto, Charla R.;
    • Rech, Karen L.;
    • Call, Timothy G.;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Hayman, Suzanne R.;
    • Koehler, Amber B.;
    • Van Dyke, Daniel L.;
    • Leis, Jose F.;
    • Slager, Susan L.;
    • Dong, Haidong;
    • Kay, Neil E.;
    • He, Rong;
    • Ding, Wei
    Publication type:
    Article
    13

    Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.

    Published in:
    2021
    By:
    • Hampel, Paul J.;
    • Parikh, Sameer A.;
    • Call, Timothy G.;
    • Shah, Mithun V.;
    • Bennani, N. Nora;
    • Al-Kali, Aref;
    • Rabe, Kari G.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Hanson, Curtis A.;
    • Van Dyke, Daniel L.;
    • Shi, Min;
    • Ding, Wei
    Publication type:
    Letter
    14

    Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 10, p. 2383, doi. 10.1080/10428194.2020.1768384
    By:
    • Koehler, Amber B.;
    • Leung, Nelson;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Achenbach, Sara J.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Hayman, Suzanne R.;
    • Hampel, Paul J.;
    • Finnes, Heidi D.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    15

    Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2712, doi. 10.1080/10428194.2019.1602268
    By:
    • Hampel, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Witzig, Thomas E.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    16

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 1, p. 143, doi. 10.1007/s00277-020-04094-3
    By:
    • Archibald, William J.;
    • Rabe, Kari G.;
    • Kabat, Brian F.;
    • Herrmann, Joerg;
    • Ding, Wei;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Chanan-Khan, Asher A.;
    • Schwager, Susan M.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Call, Timothy G.;
    • Parikh, Sameer A.
    Publication type:
    Article
    17

    Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.

    Published in:
    2018
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Shreders, Amanda;
    • Ansell, Stephen M.;
    • Kumar, Shaji;
    • Ailawadhi, Sikander;
    • King, Rebecca L.;
    • Koehler, Amber B.;
    • Reeder, Craig B.;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Dingli, David;
    • Witzig, Thomas E.;
    • Go, Ronald S.;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Leung, Nelson;
    • Habermann, Thomas M.
    Publication type:
    journal article